Jun. 3 at 4:55 PM
as posted *
$HURA $3.04 ask. BUY/3X ADD to long position carries SPM 86.94 tag. DAC (dollar average cost includes this BUY) (4)
$3.87. EXIT
$10.00
UPDATE: Secures
$12.5 million of commitments in a private offering
Secures an additional
$3.0 million through payment of cash exercise price of warrants
Funding provides capital for:
Initiation of planned Phase 3 accelerated approval trial of IFx-2.0 targeting 40% enrollment by 2-2025 year end
Acquisition of and initiating a Phase 2 trial in NPM1 mutated AML, a novel VISTA inhibiting antibody through closing of Kineta merger
Advancing first-in-class immune modulating bi-specific, and bi-functional Antibody Drug Conjugates (ADC) and Antibody Peptide Conjugates (APCs)
* Click SEARCH (magnifying glass) icon on our landing page to review the postings.
